{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:32:18Z","timestamp":1791401538437,"version":"4.3.3"},"reference-count":39,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Noordwest Ziekenhuisgroep","award":["FIO 2206"],"award-info":[{"award-number":["FIO 2206"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,9,29]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bacterial co-infections may occur in patients with influenza and respiratory syncytial virus (RSV), often leading to high unnecessary antibiotic exposure. Procalcitonin (PCT) may help reduce inappropriate antibiotic prescriptions in viral infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, data was analysed from 558 influenza A\/B and 175 RSV patients (2017\u20132024). Patients were divided into PCT (antibiotic prescription guided by PCT levels) and control groups (antibiotic prescription based on clinical judgement). Outcomes included antibiotic use, defined daily dose (DDD), duration of antibiotic treatment (DOT) and secondary outcomes (readmissions, ICU admissions, mortality, mechanical ventilation).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At admission, 139 (49.6%) of influenza patients in the control group and 148 (53.2%) in the PCT group received antibiotics (adjusted OR 1.20, 95% CI 0.79 to 1.83, p=0.325), indicating no significant difference compared with the control group. For RSV patients, 45 control patients (41.7%) and 33 PCT patients (49.3%) received antibiotics (adjusted OR 0.98, 95% CI 0.44 to 2.14, p=0.490), also showing no significant difference. For influenza, antibiotics were initiated in 175 control patients (62.7%) and 187 PCT patients (67.3%) (adjusted OR 1.25, 95% CI 0.81 to 1.92, p=0.313) during hospitalisation. For RSV, 62 control patients (57.4%) and 58 PCT patients (71.6%) received antibiotics (adjusted OR 1.30, 95% CI 0.60 to 2.89, p=0.498). No significant differences in DOT or DDD were observed for either group. PCT testing showed no significant impact on secondary outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this retrospective design, PCT testing did not significantly reduce antibiotic use or dosage, suggesting limited utility for optimising antibiotic use in influenza and RSV infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003483","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:18:01Z","timestamp":1767799081000},"page":"e003483","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Procalcitonin-guided antibiotic prescription in patients with respiratory syncytial virus and influenza virus"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0564-1064","authenticated-orcid":false,"given":"Lisa","family":"Hessels","sequence":"first","affiliation":[{"name":"Pulmonology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didi","family":"Vossen","sequence":"additional","affiliation":[{"name":"Pumonology, St Antonius Ziekenhuis, Nieuwegein, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Leeuw","sequence":"additional","affiliation":[{"name":"Emergency Department, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"Paternotte","sequence":"additional","affiliation":[{"name":"Pulmonology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Karssen","sequence":"additional","affiliation":[{"name":"Pulmonology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Chiang","sequence":"additional","affiliation":[{"name":"General practitioner, Alkmaar, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Terpstra","sequence":"additional","affiliation":[{"name":"Pulmonology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Boersma","sequence":"additional","affiliation":[{"name":"Pulmonology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"2026010123114989000_12.1.e003483.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043951"},{"key":"2026010123114989000_12.1.e003483.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-022-08586-y","article-title":"Burden of influenza hospitalization among high-risk groups in the United States","volume":"22","author":"Near","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2026010123114989000_12.1.e003483.3","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26938"},{"key":"2026010123114989000_12.1.e003483.4","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis415"},{"key":"2026010123114989000_12.1.e003483.5","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.vaccine.2021.11.080","article-title":"Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project","volume":"40","author":"Paget","year":"2022","journal-title":"Vaccine (Auckl)"},{"key":"2026010123114989000_12.1.e003483.6","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04003","article-title":"Global and national influenza-associated hospitalisation rates: Estimates for 40 countries and administrative regions","volume":"13","author":"Paget","year":"2023","journal-title":"J Glob Health"},{"key":"2026010123114989000_12.1.e003483.7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/irv.12174","article-title":"Viral-bacterial interactions-therapeutic implications","volume":"7 Suppl 3","author":"Deng","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"2026010123114989000_12.1.e003483.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-022-07089-9","article-title":"Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus","volume":"22","author":"Hedberg","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2026010123114989000_12.1.e003483.9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10096-018-3407-3","article-title":"Microorganisms associated with respiratory syncytial virus pneumonia in the adult population","volume":"38","author":"Jeanno\u00ebl","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026010123114989000_12.1.e003483.10","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12398"},{"key":"2026010123114989000_12.1.e003483.11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/infdis\/jiab525","article-title":"Predictors of Hospitalization and Superinfection in Viral Respiratory Tract Infections Between Influenza and Paramyxoviruses: The SUPERFLUOUS Study","volume":"226","author":"Lemarie","year":"2022","journal-title":"J Infect Dis"},{"key":"2026010123114989000_12.1.e003483.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01654.x"},{"key":"2026010123114989000_12.1.e003483.13","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp13X674477"},{"key":"2026010123114989000_12.1.e003483.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.09.041"},{"key":"2026010123114989000_12.1.e003483.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17907-0"},{"key":"2026010123114989000_12.1.e003483.16","doi-asserted-by":"crossref","unstructured":"Costelloe C , Metcalfe C , Lovering A , et al . Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340. doi:10.1136\/bmj.c2096","DOI":"10.1136\/bmj.c2096"},{"key":"2026010123114989000_12.1.e003483.17","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.23.46.1800393","article-title":"Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017","volume":"23","author":"Plachouras","year":"2018","journal-title":"Euro Surveill"},{"key":"2026010123114989000_12.1.e003483.18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajem.2021.03.018","article-title":"Antibiotic utilization for adult acute respiratory tract infections in United States Emergency Departments","volume":"47","author":"Schroeder","year":"2021","journal-title":"Am J Emerg Med"},{"key":"2026010123114989000_12.1.e003483.19","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz410"},{"key":"2026010123114989000_12.1.e003483.20","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90277-N"},{"key":"2026010123114989000_12.1.e003483.21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4414\/smw.2001.09751","article-title":"Procalcitonin: how a hormone became a marker and mediator of sepsis","volume":"131","author":"M\u00fcller","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"2026010123114989000_12.1.e003483.22","doi-asserted-by":"publisher","DOI":"10.1086\/421997"},{"key":"2026010123114989000_12.1.e003483.23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.5.1054"},{"key":"2026010123114989000_12.1.e003483.24","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000226413.54364.36"},{"key":"2026010123114989000_12.1.e003483.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15591-8"},{"key":"2026010123114989000_12.1.e003483.26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1297"},{"key":"2026010123114989000_12.1.e003483.27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2023.04.032","article-title":"Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19: A Multicenter Observational Cohort Study","volume":"164","author":"Hessels","year":"2023","journal-title":"Chest"},{"key":"2026010123114989000_12.1.e003483.28","first-page":"4","article-title":"Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT)","volume":"76","author":"Wiersinga","year":"2018","journal-title":"Neth J Med"},{"key":"2026010123114989000_12.1.e003483.29","unstructured":"National Institute for Public Health and the Environment (RIVM) . LCI guideline: influenza. Bilthoven RIVM; 2024. Available: https:\/\/lci.rivm.nl\/richtlijnen\/influenza"},{"key":"2026010123114989000_12.1.e003483.30","unstructured":"National institute for public health and the environment (RIVM) . Lci guideline: respiratory syncytial virus (RSV). Bilthoven RIVM; 2024. Available: https:\/\/lci.rivm.nl\/richtlijnen\/rsv"},{"key":"2026010123114989000_12.1.e003483.31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200512-1922OC"},{"key":"2026010123114989000_12.1.e003483.32","unstructured":"Norwegian Institute of Public Health . ATC\/ddd index 2024. 2025. Available: https:\/\/atcddd.fhi.no\/atc_ddd_index\/"},{"key":"2026010123114989000_12.1.e003483.33","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","volume":"10","author":"Schuetz","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010123114989000_12.1.e003483.34","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1515\/cclm-2018-0126","article-title":"Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysis","volume":"56","author":"Hey","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2026010123114989000_12.1.e003483.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802670"},{"key":"2026010123114989000_12.1.e003483.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-011-2189-1"},{"key":"2026010123114989000_12.1.e003483.37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix317"},{"key":"2026010123114989000_12.1.e003483.38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1473-3099(21)00255-3","article-title":"Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial","volume":"22","author":"Schweitzer","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2026010123114989000_12.1.e003483.39","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/cid\/ciz1042","article-title":"Use of Procalcitonin and a Respiratory Polymerase Chain Reaction Panel to Reduce Antibiotic Use via an Electronic Medical Record Alert","volume":"71","author":"Moradi","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:18:05Z","timestamp":1767799085000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,10]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjresp-2025-003483"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003483","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}